Advertisement

Topics

German Biotech closes Largest Series A Fundraising of 2017 So Far

06:00 EST 8 Mar 2017 | Labiotech.eu

Breath Therapeutics has raised €43.5M that will be used to finalize development and launch a therapy to improve survival in lung transplant patients. Sofinnova Partners, one of the top biotech VCs in Europe, and the Belgian Gimv have co-led the ...

This awesome article German Biotech closes Largest Series A Fundraising of 2017 So Far appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: German Biotech closes Largest Series A Fundraising of 2017 So Far

NEXT ARTICLE

More From BioPortfolio on "German Biotech closes Largest Series A Fundraising of 2017 So Far"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...